Mitral regurgitation caused by chronic ergotamine use.
Flaherty
K R
KR
Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Bates
J R
JR
D000328:Adult; D002110:Caffeine / Q000009:adverse effects* / Q000627:therapeutic use; D002908:Chronic Disease; D004338:Drug Combinations; D004878:Ergotamine / Q000009:adverse effects* / Q000627:therapeutic use; D004881:Ergotism / Q000150:complications* / Q000175:diagnosis; D005260:Female; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D008944:Mitral Valve Insufficiency / Q000139:chemically induced* / Q000175:diagnosis; D013375:Substance Withdrawal Syndrome / Q000150:complications / Q000175:diagnosis
D004338:Drug Combinations; C037330:caffeine, ergotamine drug combination; D002110:Caffeine; D004878:Ergotamine